Code | Sex, Age | Severitya | Medical historyb | Hospitalization duration | Upper respiratory symptomc | Pneumonia | Persistent imaging abnormalities | Ventilator introduction (dpod) | Ventilator removal (dpod) | Treatmente | Equipmentf | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|
K-Px-10 | M, 59 | Asymptomatic | DM, glaucoma | 20 | – | n.d. | n.d. | – | – | – | – | Alive |
K-Px-13 | M, 54 | Asymptomatic | – | 8 | – | n.d. | n.d. | – | – | – | – | Alive |
K-Px-14 | F, 54 | Asymptomatic | DM | 8 | – | n.d. | n.d. | – | – | – | – | Alive |
K-Px-15 | M, 19 | Asymptomatic | – | 9 | – | n.d. | n.d. | – | – | – | – | Alive |
K-Px-16 | M, 19 | Asymptomatic | – | 2 | – | n.d. | n.d. | – | – | – | – | Alive |
K-Px-12 | M, 71 | Severe | AR, BA, BPH | 35 | + | + | + | – | – | C | – | Alive |
K-Px-1 | F, 59 | Severe | Cervical cancer, HL, HT, SAS | 23 | + | + | + | – | – | C, F | – | Alive |
K-Px-9 | F, 69 | Severe | HL, HT | 21 | + | + | + | – | – | C, F | – | Alive |
K-Px-2 | M, 57 | Critical | – | 56 | + | + | + | 8 | 33 | F, L/R | CHDF, HD | Alive |
K-Px-3 | M, 74 | Critical | DM, glaucoma, HL | 44 | + | + | + | 11 | 50 | C, F, L/R | CHDF | Dead (51 dpod) |
K-Px-4 | F, 63 | Critical | Osteoporosis | 80 | + | + | + | 16 | 65 | C, F, L/R | ECMO | Alive |
K-Px-5 | M, 65 | Critical | HT, hyperuricemia | 93 | + | + | – | 12 | 32 | C, F, L/R | CHDF | Alive |
K-Px-6 | M, 79 | Critical | Arrhythmia, CI, dementia | 16 | + | + | + | 6 | 15 | C, F, L/R | – | Dead (16 dpod) |
K-Px-7 | M, 78 | Critical | AAA, AP, arrhythmia, ASO, CHF, CKD, DM, GB, HT | 17 | + | + | + | 8 | 21 | C, F | – | Dead (22 dpod) |
K-Px-8 | F, 79 | Critical | DM, IgA nephropathy | 73 | + | + | + | 0 | 36 | F, L/R, Steroid (6-9 dpod) | CRRT | Alive |